API manufacturers reaped the benefits of a supply-chain shift from China, while drug manufacturers benefited from faster drug approvals by the USFDA
API manufacturers reaped the benefits of a supply-chain shift from China, while drug manufacturers benefited from faster drug approvals by the USFDA
from https://ift.tt/3sXU1i0